Because of its major role in regulating platelet functions and its prominen
ce on the cell surface, integrin alpha (IIb)beta (3) has been the subject o
f intensive investigations. Such studies have provided substantial insights
into its structure-function relationships and have led to the development
of anti-thrombotic drugs that target the receptor. Nevertheless, recent fin
dings have indicated that our understanding of the structure and function o
f alpha (IIb)beta (3) remains inadequate. This article addresses two aspect
s of still evolving alpha (IIb)beta (3) function: 1) the interface between
alpha (IIb)beta (3) and the blood coagulation system, resulting from intera
ction of prothrombin with the receptor; and 2) the molecular basis for reco
gnition of the RGD and the fibrinogen gamma -chain peptide ligands by alpha
(IIb)beta (3). As illustrated by these two examples, there is still much t
o be learned about alpha (IIb)beta (3) if we are to fully appreciate its fu
nctions and its potential as a therapeutic target.